Reports > Life Sciences > Antimicrobial Susceptibility Testing Market Report
Antimicrobial Susceptibility Testing Market Size, Share, Industry Trends and Forecast to 2033
This report provides a comprehensive analysis of the Antimicrobial Susceptibility Testing market, focusing on market dynamics, trends, regional insights, and future forecasts between 2023 and 2033.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | BioMerieux, Thermo Fisher Scientific, Becton Dickinson, Cepheid |
| Last Modified Date | 15 Nov 2024 |
Antimicrobial Susceptibility Testing Market Report (2023 - 2033)
Antimicrobial Susceptibility Testing Market Overview
What is the Market Size & CAGR of Antimicrobial Susceptibility Testing market in 2023?
Antimicrobial Susceptibility Testing Industry Analysis
Antimicrobial Susceptibility Testing Market Segmentation and Scope
Request a custom research report for industry.
Antimicrobial Susceptibility Testing Market Analysis Report by Region
Europe Antimicrobial Susceptibility Testing Market Report:
Europe accounted for $0.64 billion of the market share in 2023, with forecasts predicting growth to $1.26 billion by the end of 2033. Increasing prevalence of infectious diseases and strict mandates for infection prevention further accelerate market expansion.Asia Pacific Antimicrobial Susceptibility Testing Market Report:
In the Asia Pacific region, the Antimicrobial Susceptibility Testing market was valued at $0.49 billion in 2023 and is projected to reach $0.97 billion by 2033. The growth is driven by increasing investments in healthcare infrastructure and rising awareness regarding antibiotic resistance.North America Antimicrobial Susceptibility Testing Market Report:
North America dominated the Antimicrobial Susceptibility Testing market with an estimated value of $0.83 billion in 2023, expected to grow to $1.64 billion by 2033. High demand for advanced diagnostic technologies and strong government regulations related to infection control contribute to this growth.South America Antimicrobial Susceptibility Testing Market Report:
The South American market segment recorded a value of $0.21 billion in 2023, with expectations to double to $0.42 billion by 2033. Increasing healthcare initiatives and rising government investment in infectious disease control are key growth factors for this market.Middle East & Africa Antimicrobial Susceptibility Testing Market Report:
In the Middle East and Africa, the AST market was valued at $0.32 billion in 2023, aiming for $0.63 billion by 2033. The rising incidence of infectious diseases and improving healthcare access in the region are pivotal factors for growth.Request a custom research report for industry.
Antimicrobial Susceptibility Testing Market Analysis By Product Type
Global Antimicrobial Susceptibility Testing Market, By Product Type Market Analysis (2023 - 2033)
In 2023, the product types like Broth Micro-dilution and Automated Systems accounted for significant shares. Broth Micro-dilution is expected to hold a dominant market share of approximately 64.16% in 2023, while Automated Systems are anticipated to grow from $0.58 billion to $1.15 billion by 2033.
Antimicrobial Susceptibility Testing Market Analysis By Methodology
Global Antimicrobial Susceptibility Testing Market, By Methodology Market Analysis (2023 - 2033)
Broth micro-dilution techniques lead the AST methodologies held an expected market share of 64.16% in 2023. Agar diffusion techniques followed with 23.34% of the market share, showcasing their critical role in susceptibility testing for clinical settings.
Antimicrobial Susceptibility Testing Market Analysis By Organism Type
Global Antimicrobial Susceptibility Testing Market, By Organism Type Market Analysis (2023 - 2033)
The bacteria segment dominates the market, holding a significant 64.16% well into the forecasted period. The fungi and viruses segments are also growing but have smaller market shares of 23.34% and 12.5% respectively.
Antimicrobial Susceptibility Testing Market Analysis By End User
Global Antimicrobial Susceptibility Testing Market, By End-User Market Analysis (2023 - 2033)
Hospitals lead this segment with a market share of 55.57% in 2023, expected to maintain steady growth due to the high patient turnover and sheer volume in diagnostic testing. Diagnostic laboratories and research institutes follow closely with shares of 24.52% and 9.98%, respectively.
Antimicrobial Susceptibility Testing Market Analysis By Region
Global Antimicrobial Susceptibility Testing Market, By Region Market Analysis (2023 - 2033)
Geographically, North America has a commanding presence, while regions like Asia Pacific are expected to witness rapid growth, attributed to increasing healthcare investments and rising awareness of antimicrobial resistance. Europe remains strong due to regulatory requirements for high standards in testing.
Antimicrobial Susceptibility Testing Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Antimicrobial Susceptibility Testing Industry
BioMerieux:
A leading company specializing in the development of microbiological tools, BioMerieux delivers robust solutions for Infectious Disease testing and is well-known for its advanced AST products.Thermo Fisher Scientific:
Known for cutting-edge technology, Thermo Fisher provides a range of AST solutions, innovative products, and advanced laboratory services, aiding in combating antimicrobial resistance.Becton Dickinson:
Becton Dickinson's comprehensive product line in Diagnostic tools makes it a crucial player in the market, focusing on enhancing patient and laboratory outcomes in susceptibility testing.Cepheid:
Cepheid is renowned for its automated molecular testing, and offers groundbreaking solutions in rapid diagnostic testing, impacting significantly on antibiotic susceptibility testing.We're grateful to work with incredible clients.
